Azurity Pharmaceuticals: Anemia trials

The registry lists 15 Anemia studies with Azurity Pharmaceuticals as lead sponsor. 1 are open to participants now and 9 have results posted.

Phase 1 1Phase 2 1Phase 3 12Phase 4 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric SubjectsRecruitingNCT03893045Phase 3
• A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)CompletedNCT02694978Phase 3Results posted
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney DiseaseTerminatedNCT01264679Phase 3Results posted
• Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on HemodialysisCompletedNCT01227616Phase 4Results posted
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney DiseaseTerminatedNCT01155388Phase 3Results posted
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney DiseaseTerminatedNCT01155375Phase 3Results posted
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency AnemiaCompletedNCT01114217Phase 3Results posted
• A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency AnemiaCompletedNCT01114204Phase 3Results posted
• A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency AnemiaCompletedNCT01114139Phase 3Results posted
• A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney DiseaseCompletedNCT01052779Phase 2Results posted
• A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and WomenCompletedNCT00360425Phase 1
• A Crossover Safety Study of Ferumoxytol Versus PlaceboCompletedNCT00255450Phase 3
• Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease PatientsCompletedNCT00255437Phase 3
• Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease PatientsCompletedNCT00255424Phase 3
• Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis PatientsCompletedNCT00233597Phase 3